Rheumatology International

, Volume 25, Issue 2, pp 114–117 | Cite as

The effect of low-dose prednisone on bone mineral density in Peruvian rheumatoid arthritis patients

  • Cecilia P. Chung
  • Anthony S. Russell
  • Maria I. Segami
  • César A. Ugarte
Original Article
First Online:
Received:
Accepted:

Abstract

Objective

The aim of this study was to determine the difference between bone mineral density (BMD) of rheumatoid arthritis (RA) patients on low-dose prednisone and matched RA patients without prior systemic corticosteroid therapy.

Methods

Ninety patients attending our clinics and receiving 10 mg/day of prednisone or less for at least the previous 3 consecutive months were studied. The control group comprised 90 selected RA patients without corticosteroid therapy matched for age, race, gender, disease duration, use of methotrexate, postmenopause, and Health Assessment Questionnaire score. The BMD was measured using dual X-ray absorptiometry.

Results

Patients on prednisone had lower BMD than controls (0.94±0.17 vs 0.96±0.17 for L2–4 and 0.73±0.14 vs 0.76±0.16 for femoral neck), but these differences were not statistically significant (P>0.05). In post hoc analysis, postmenopausal women on prednisone had more bone loss in femoral neck than controls (0.68±0.13 vs 0.74±0.15).

Conclusion

Bone mineral density was not significantly reduced by low-dose prednisone in this diverse group of RA patients. A reduction in hip BMD was seen in postmenopausal women on prednisone.

Keywords

Bone mineral density Corticosteroids Osteoporosis Prednisone Rheumatoid arthritis 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Gough AK, Likey J, Eyre S, Holder RL, Emery P (1994) Generalized bone loss in patients with early rheumatoid arthritis. Lancet 344:23–27PubMedGoogle Scholar
  2. 2.
    Kroot EJ, Nieuwenhuizen M, de Waal Malefijt MC et al (2001) Change in bone mineral density in patients with rheumatoid arthritis during the first decade of disease. Arthritis Rheum 44:1254–1260CrossRefPubMedGoogle Scholar
  3. 3.
    Shenstone BD, Mahmoud A, Woodward R et al (1994) Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol 33:541–545PubMedGoogle Scholar
  4. 4.
    Lann RF, Van Riel PL, Van de Putte LB, Van Erning LJ, Van’t Hof MA, Lemmens AM (1993) Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med 119:963–968PubMedGoogle Scholar
  5. 5.
    Verstraeten A, Dequeker J (1986) Vertebral and peripheral bone mineral content and fracture incidence in post-menopausal patients with rheumatoid arthritis. Ann Rheum Dis 45:852–857PubMedGoogle Scholar
  6. 6.
    Als OS, Gotfredsen A, Riss BJ, Christiansen C (1985) Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis? Ann Rheum Dis 44:406–411PubMedGoogle Scholar
  7. 7.
    Deodhar AA, Woolf AD (1996) Bone mineral measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 35:309–322PubMedGoogle Scholar
  8. 8.
    Kroot EJ, Laan RF (2000) Bone mass in rheumatoid arthritis. Clin Exp Rheumatol 18 [Suppl 21]:S12–S15Google Scholar
  9. 9.
    Lau EM (2001) Epidemiology of osteoporosis. Best Pract Res Clin Rheumatol 3:335–344CrossRefGoogle Scholar
  10. 10.
    Saag KG, Koenhne R, Caldwell JR et al (1994) Low dose long-term corticosteroid therapy in RA: an analysis of serious adverse events. Am J Med 96:115–123PubMedGoogle Scholar
  11. 11.
    Cushing H (1932) The basophile adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 50:137–195Google Scholar
  12. 12.
    Martin JL, Munro R, Campbell MK, Reid DM (1997) Effect of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol 36:43–49PubMedGoogle Scholar
  13. 13.
    Hall GM, Spector TD, Griffin J, Jawad, AS, Hall M, Doyle DV (1993) The effect of rheumatoid arthritis and steroid therapy on bone mineral density in postmenopausal women. Arthritis Rheum 36:1510–1516PubMedGoogle Scholar
  14. 14.
    Butler RC, Davie MW, Worsfold M, Sharp A (1991) Bone mineral content in patients with rheumatoid arthritis: relationship to low-dose steroid therapy. Br J Rheum 30:86–90Google Scholar
  15. 15.
    Laan RF, Van Riel PL, Van Erning O, Lemmens JA, Ruijs HJ, Van de Putte LB (1992) Vertebral osteoporosis in RA patients. Effect of low dose prednisone therapy. Br J Rheumatol 31:91–96PubMedGoogle Scholar
  16. 16.
    Saario R, Sonninen P, Mottonen T, Viikari J, Toivanen A (1999) Bone mineral density of the lumbar spine in patients with advance rheumatoid arthritis. Influence of functional capacity and corticosteroid use. Scan J Rheumatol 28:363–367CrossRefGoogle Scholar
  17. 17.
    Haugeber G, Orstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK (2002) Bone loss in patients with rheumatoid arthritis. Results from a population-based cohort of 336 patients followed up for two years. Arthritis Rheum 46:1720–1728CrossRefPubMedGoogle Scholar
  18. 18.
    Sambrook PN, Eisman JA, Yeates MG, Pocock NA, Eberl S, Champion GD (1986) Osteoporosis in RA: safety of low dose corticosteroids. Ann Rheum Dis 45:950–953PubMedGoogle Scholar
  19. 19.
    Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG (1989) Effect of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 48:535–538PubMedGoogle Scholar
  20. 20.
    Sambrook P, Raj A, Hunter D, Naganathan V, Mason R, Robinson B (2001) Osteoporosis with low dose corticosteroids. Contribution of underlying disease effect and discriminatory ability of ultrasound versus bone densitometry. J Rheum 28:1063–1067PubMedGoogle Scholar
  21. 21.
    Arnett FC, Edworthy SM, Block DA et al (1988) American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedGoogle Scholar
  22. 22.
    Glave C, Segami MI, Ugarte C et al (1996) Validación multicéntrica inicial de la versión Peruana del índice de incapacidad funcional (Health Assessment Questionnaire). Anales de la Facultad de Medicina U.N.M.S.M 57:174–178Google Scholar
  23. 23.
    Boulus P, Adachi JD (2000) Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis. Clin Exp Rheumatol 18 [Suppl 21]:S35–S40Google Scholar
  24. 24.
    Reid IR (1997) Preventing glucocorticoid-induced osteoporosis. N Engl J Med 337:420–421CrossRefPubMedGoogle Scholar
  25. 25.
    Solomon DH, Kuntz KM (2000) Should postmenopausal women with rheumatoid arthritis who are starting corticosteroids treatment be screened for osteoporosis? Arthritis Rheum 43:1967–1975CrossRefPubMedGoogle Scholar
  26. 26.
    Weinstein RS (2000) The pathogenesis of glucocorticoid-induced osteoporosis. Clin Exp Rheumatol 18 [Suppl 21]:S35–S40Google Scholar
  27. 27.
    Adachi J, Bensen WG, Hodsman AB (1993) Corticosteroid-induced osteoporosis. Semin Arthritis Rheum 22:375–384PubMedGoogle Scholar
  28. 28.
    Van Everdinger AA, Siewertsz Van Reesema DR, Jacobs JW, Biljsma JW (2003) Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures? Clin Exp Rheumatol 21:155–160PubMedGoogle Scholar
  29. 29.
    Hougardy DM, Peterson GM, Bleasel MD, Randall TC (2000) Is enough attention being given to the adverse effects of corticosteroid therapy? J Clin Pharm Ther 25: 227–234CrossRefPubMedGoogle Scholar
  30. 30.
    Criswell LA, Redfearn WJ (1994) Variation among rheumatologists in the use of prednisone and second-line agents for the treatment of rheumatoid arthritis. Arthritis Rheum 37:476–480PubMedGoogle Scholar
  31. 31.
    Wilske KR (1993) Inverting the therapeutic pyramid: observations and recommendations on new directions in rheumatoid arthritis therapy based on the author’s experience. Semin Arthritis Rheum 23 [2 Suppl 1]:11–18Google Scholar
  32. 32.
    Nijs RN, Jacobs JW, Bijlsma J et al (2001) Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology 40:1375–1383CrossRefPubMedGoogle Scholar
  33. 33.
    Peel NF, Moore DJ, Barrington NA, Box DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54:801–806PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Cecilia P. Chung
    • 1
  • Anthony S. Russell
    • 2
    • 5
  • Maria I. Segami
    • 3
  • César A. Ugarte
    • 4
  1. 1.Division of RheumatologyUniversity of AlbertaEdmontonCanada
  2. 2.University of AlbertaEdmontonCanada
  3. 3.Rheumatology Service, Hospital E. RebagliatiUniversidad Nacional Mayor de San MarcosLimaPeru
  4. 4.Universidad Nacional Mayor de San MarcosLimaPeru
  5. 5.562 Heritage Medical Research CentreUniversity of AlbertaEdmontonCanada T6G 2S2

Personalised recommendations